Medable launched its Digital Data Flow (DDF) Agent to convert static clinical trial protocols into machine-readable, standardized data in CDISC USDM 4.0 JSON format. The company says the agent can generate electronic clinical outcome assessments quickly while maintaining alignment with source protocols and downstream systems. The product is designed to address a recurring bottleneck in trial execution: protocols exist as document-based artifacts that require substantial manual interpretation when translated into study systems. Medable’s approach aims to propagate protocol changes after approval across connected documents and workflows. The company also framed the release as aligning with FDA’s broader push toward real-time clinical trials, where continuous data review and operational responsiveness require traceable endpoint and safety-signal workflows. For biotech sponsors, an automation layer that reduces protocol-to-systems manual handoffs could lower operational risk and shorten amendment cycles.